trametinib,dabrafenib,pdr001
novartis
['melanoma', 'combi-i']
#esmo22 | poster session 3 | saturday
predictive role of neutrophil-lymphocyte ratio (nlr) in patients (pts) with metastatic melanoma: a post hoc exploratory analysis from phase iii combi-i trial
co-author: keith flaherty, md 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.